Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $21.96 in the prior trading day, NovoCure Ltd (NASDAQ: NVCR) closed at $19.23, down -12.43%. In other words, the price has decreased by -$12.43 from its previous closing price. On the day, 2.8 million shares were traded.
Ratios:
Our goal is to gain a better understanding of NVCR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.44 and its Current Ratio is at 1.49. In the meantime, Its Debt-to-Equity ratio is 1.87 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on December 02, 2024, Upgraded its rating to Outperform and sets its target price to $30 from $18 previously.
On October 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $24 to $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 27 ’25 when MUKUND PARAVASTHU bought 1,646 shares for $20.02 per share.
ASHLEY CORODVA bought 11,153 shares of NVCR for $223,322 on Feb 27 ’25. On Feb 27 ’25, another insider, WILHELMUS GROENHUYSEN, who serves as the Officer of the company, bought 7,211 shares for $20.02 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.60 while its Price-to-Book (P/B) ratio in mrq is 5.76.
Stock Price History:
Over the past 52 weeks, NVCR has reached a high of $34.13, while it has fallen to a 52-week low of $11.70. The 50-Day Moving Average of the stock is -26.67%, while the 200-Day Moving Average is calculated to be -7.64%.
Shares Statistics:
A total of 108.10M shares are outstanding, with a floating share count of 97.30M. Insiders hold about 10.08% of the company’s shares, while institutions hold 85.00% stake in the company.
